Answer
Mometasone furoate administered as an aqueous nasal spray has systemic bioavailability of less than 1% in plasma, measured using a sensitive assay with a lower quantitation limit of 0.25 pg/ml.
Sources for this answer
- Nasonex 50 micrograms/actuation Nasal Spray, SuspensionOrganon Pharma (UK) Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 19Document updated
Sources checked